Related Experiment Videos
[Erythrocyte aggregation and fibrinogen derivatives in ischemic heart disease]
Insights
Erythrocyte aggregation, a key factor in blood flow, is significantly increased in patients with ischemic heart disease. This heightened aggregation, linked to fibrinogen, impacts blood flow dynamics and may contribute to disease progression.
Area of Science:
- Cardiovascular Science
- Hematology
- Biophysics
Background:
- Erythrocyte aggregation influences blood rheology and microcirculation.
- Ischemic heart disease (IHD) involves impaired blood flow due to coronary artery disease.
- Understanding erythrocyte behavior is crucial for IHD pathophysiology.
Purpose of the Study:
- To investigate erythrocyte aggregation in patients with angina pectoris and myocardial infarction.
- To compare aggregation patterns between IHD patients and healthy controls.
- To identify factors contributing to altered erythrocyte aggregation in IHD.
Main Methods:
- Rheoscopy according to Schmid-Schoenbein was employed.
- Erythrocyte aggregation was measured in 50 IHD patients and 20 controls.
- Aggregation curves were analyzed for characteristic patterns.
Main Results:
- Patients with IHD exhibited significantly increased erythrocyte aggregation.
- The hydrodynamic strength of erythrocyte aggregates was greater in IHD patients.
- A biexponential aggregation curve was observed in some IHD patients, unlike the monoexponential curve in controls.
Conclusions:
- Increased erythrocyte aggregation and aggregate strength are characteristic of IHD.
- Fibrinogen and its complexes with degradation products are implicated in enhanced aggregation.
- These rheological changes may play a role in the pathophysiology of ischemic heart disease.
Abstract:
Aggregation of erythrocytes was determined in 50 patients with angina pectoris and myocardial infarction and in 20 subjects of the control group by rheoscopy after Schmid-Schoenbein. It is shown that in patients with ischemic heart disease aggregation of erythrocytes is considerably increased and the hydrodynamic strength of the aggregates is greater. The erythrocyte aggregation curve is some patients with ischemic heart disease was of a biexponential character in distinction to that in subjects of the control group, which was of the monoexponential type. It was found that the increase in the strength of the erythrocyte aggregation and in the rate of aggregate formation was due to fibrinogen and its complex compounds with decomposition products.